Validation, Commissioning & Design Featured Articles
-
Selecting The Right eQMS To Maximize Quality Maturity
4/23/2026
Let's take a closer look at the current electronic quality management system (eQMS) landscape in pharma/biotech and what a future-ready eQMS must enable to support continuous improvement.
-
Digital Process Twin Cuts J&J Production Time And Costs
4/22/2026
Virtual process modeling is helping to cut production time, reduce solvent use, and improve sustainability. Learn how digital twins enable faster scale‑up decisions and more efficient manufacturing.
-
How Do You Navigate GxP Compliance?
4/21/2026
Heightened FDA scrutiny demands a shift from fragmented data to unified digital systems. Learn how to automate QA tasks, secure data integrity, and maintain a constant state of inspection readiness.
-
How Can Bioprocessing Professionals Evolve Their Manufacturing For Greater Flexibility And Efficiency?
4/21/2026
Manufacturing flexibility is now a competitive differentiator. Here's how single-use technologies are reshaping bioprocessing facility design, scalability, and sustainability strategy.
-
The Hidden Operational Cost Contained In Every Small Molecule Portfolio
4/21/2026
The volume of post-approval changes is rising and the manual approaches that have worked until now are no longer adequate. Get ahead of this to spend less and execute faster.
-
Material Transfer Into A Cleanroom: How To Reduce Contamination Risk At Every Step
4/20/2026
Evaluate packaging integrity and master wiping techniques to prevent cleanroom contamination. Focus on surface coverage and controlled transfer paths to ensure consistent product safety and quality.
-
A New Standard For Production Efficiency And GxP Compliance
4/20/2026
Traditional MES platforms were built for stable environments that no longer exist. Manufacturers are now adopting composable execution architectures to reduce friction and adapt faster.
-
Why Composable Manufacturing Execution Is Becoming The New Standard
4/20/2026
Low-code MES promises speed, but agility comes from ownership. Composable, no-code approaches give operations teams the ability to change workflows themselves and respond faster to disruption.
-
FDA's New Flexible CMC Framework For CGT
4/14/2026
The FDA is rethinking CMC oversight for cell and gene therapies, prioritizing science‑based justification over rigid validation models. Learn how this lifecycle‑focused approach could reduce burden.
-
MTP And "The Ballroom Concept": Agile Manufacturing For Pharma
4/14/2026
Modular automation is reshaping manufacturing by enabling faster changeovers, reduced downtime, and built‑in compliance. Learn how the “ballroom” approach helps teams adapt to shifting demand.